All Stories

  1. Identification of bi‐allelic LFNG variants in three patients and further clinical and molecular refinement of spondylocostal dysostosis 3
  2. Editorial: Hypertensive disorders of pregnancy and the cardiovascular system: Causes, consequences, prevention and treatment
  3. Anthropometric Features and Third-Fourth Degree Perineal Tears
  4. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum
  5. Role of fetal magnetic resonance imaging in fetuses with congenital cytomegalovirus infection: multicenter study
  6. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study
  7. Reduced fetal growth velocity and weight loss are associated with adverse perinatal outcome in fetuses at risk of growth restriction
  8. Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 pregnancies
  9. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort
  10. Sex-dependent association between variability in infants’ OXTR methylation at birth and negative affectivity at 3 months
  11. Referral scan for congenital anomalies: time to agree on indications
  12. Current practice in the diagnosis and management of fetal growth restriction: An international survey
  13. Post-partum Women’s Anxiety and Parenting Stress: Home-Visiting Protective Effect During the COVID-19 Pandemic
  14. Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters
  15. Maternal Right Ventricular and Left Atrial Function in Uncomplicated Twin Pregnancies: A Longitudinal Study
  16. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies
  17. Maternal Left Ventricular Function in Uncomplicated Twin Pregnancies: A Speckle-Tracking Imaging Longitudinal Study
  18. Third‐trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study
  19. Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study
  20. Risk factors for anxiety and depression among pregnant women during COVID ‐19 pandemic—Results of a web‐based multinational cross‐sectional study
  21. Is Brain-Derived Neurotropic Factor Methylation Involved in the Association Between Prenatal Stress and Maternal Postnatal Anxiety During the COVID-19 Pandemic?
  22. An update of diagnostic efficacy of ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
  23. Diabetes mellitus, maternal adiposity, and insulin-dependent gestational diabetes are associated with COVID-19 in pregnancy: the INTERCOVID study
  24. Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study)
  25. Ultrasound and MRI appearance of abnormally adherent placenta in a woman with Asherman's syndrome
  26. Incidence, clinical features and perinatal outcome in anomalous fetuses with late‐onset growth restriction: cohort study
  27. ISUOG Practice Guidelines (updated): performance of the routine mid‐trimester fetal ultrasound scan
  28. Timing of intra‐fetal laser therapy for twin reversed arterial perfusion ( TRAP ) sequence: Retrospective series and systematic review and meta‐analysis
  29. Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks
  30. Not yet the last word on fundal pressure
  31. Perinatal and 2-year neurodevelopmental outcome in late preterm fetal compromise: the TRUFFLE 2 randomised trial protocol
  32. Exclusive breastfeeding and maternal postnatal anxiety contributed to infants' temperament issues at 6 months of age
  33. Inappropriate left ventricular mass after HELLP syndrome inappropriate LVM after HELLP syndrome
  34. Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach
  35. Organization of an obstetrics unit during the COVID-19 pandemic: a short literature review
  36. HLA class I and HPA9b related fetal‐neonatal alloimmune thrombocytopenia
  37. Obstetric consequences of a false‐positive diagnosis of large‐for‐gestational‐age fetus
  38. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
  39. Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy
  40. In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19
  41. Role of prenatal magnetic resonance imaging in fetuses with isolated severe ventriculomegaly at neurosonography: A multicenter study
  42. Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case–control study in Italy (the MODEL-PLACENTA study)
  43. Longitudinal Doppler Assessments in Late Preterm Fetal Growth Restriction
  44. Fetal cerebral blood‐flow redistribution: analysis of Doppler reference charts and association of different thresholds with adverse perinatal outcome
  45. Fetoscopic laser ablation therapy in monochorionic diamniotic twin pregnancies with twin-to-twin transfusion syndrome treated at a single centre over 10 years: a retrospective study
  46. Depression and Anxiety in Mothers Who Were Pregnant During the COVID-19 Outbreak in Northern Italy: The Role of Pandemic-Related Emotional Stress and Perceived Social Support
  47. Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study
  48. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
  49. The hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants’ temperament at 3 months
  50. External validation of prognostic models to predict stillbirth using the International Prediction of Pregnancy Complications ( IPPIC ) Network database: an individual participant data meta‐analysis
  51. Hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants’ temperament at 3 months
  52. ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics
  53. Prenatal maternal stress during the COVID-19 pandemic and infant regulatory capacity at 3 months: A longitudinal study
  54. Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study
  55. Maternal myocardial dysfunction after hemolysis, elevated liver enzymes, and low platelets syndrome: a speckle-tracking study
  56. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
  57. Pre-eclampsia and late fetal growth restriction
  58. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection
  59. Childbirth Care among SARS-CoV-2 Positive Women in Italy
  60. Maternal and neonatal outcomes of pregnancies complicated by late fetal growth restriction undergoing induction of labor with dinoprostone compared with cervical balloon: A retrospective, international study
  61. Pregnancy and COVID‐19: Do not overlook malaria
  62. Maternal hemodynamics, arterial stiffness and elastic aortic properties in twin pregnancy
  63. Measuring the Outcomes of Maternal COVID-19-related Prenatal Exposure (MOM-COPE): study protocol for a multicentric longitudinal project
  64. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
  65. Assessing risk factors for severe forms of COVID‐19 in a pregnant population: A clinical series from Lombardy, Italy
  66. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis
  67. The Impact of Preeclampsia on Women’s Health: Cardiovascular Long-term Implications
  68. Prenatal diagnosis of fetal anomalies from the third to the first trimester and back
  69. Retest positive for SARS‐CoV‐2 RNA of recovered pregnant women with COVID‐19
  70. Pregnancy prolongation for pre‐eclampsia: the obvious and the avoidable
  71. The MOM-COPE research project: Measuring the outcomes of maternal COVID19-related prenatal exposure
  72. Possible Coronavirus Disease 2019 Pandemic and Pregnancy
  73. SARS-CoV-2 infection testing at delivery: a clinical and epidemiological priority
  74. Standardising definitions for the pre-eclampsia core outcome set: A consensus development study
  75. Folic Acid Supplementation in Pregnancy
  76. Outcomes in Pregnancies With a Confined Placental Mosaicism and Implications for Prenatal Screening Using Cell-Free DNA
  77. Fetal cerebral Doppler changes and outcome in late preterm fetal growth restriction: prospective cohort study
  78. Maternal myocardial dysfunction after normotensive fetal growth restriction compared with hypertensive pregnancies: a speckle-tracking study
  79. Current use and performance of the different fetal growth charts in the Italian population
  80. ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID‐19
  81. ISUOG Interim Guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and puerperium: information for healthcare professionals – an update
  82. Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: a retrospective analysis
  83. COVID ‐19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome
  84. A core outcome set for pre‐eclampsia research: An international consensus development study
  85. ISUOG Practice Guidelines: role of ultrasound in congenital infection
  86. Twin Reversed Arterial Perfusion Sequence: Current Treatment Options
  87. Identification of large-for-gestational age fetuses using antenatal customized fetal growth charts: Can we improve the prediction of abnormal labor course?
  88. Reply
  89. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre‐eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study
  90. Core outcome set for studies investigating management of selective fetal growth restriction in twins
  91. A case of combined aortic bioprosthetic valve degeneration and patient–prosthesis mismatch during pregnancy
  92. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals
  93. Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity
  94. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study
  95. Genome‐wide cfDNA testing of maternal blood
  96. Antepartum and intrapartum risk factors for neonatal hypoxic–ischemic encephalopathy
  97. Ductus venosus Doppler waveform pattern in fetuses with early growth restriction
  98. Perinatal outcomes of fetal intra-abdominal umbilical vein varix: a multicenter cohort study
  99. Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses
  100. Outcome of twin‐to‐twin transfusion syndrome in monochorionic monoamniotic twin pregnancies: a systematic review and meta‐analysis
  101. Prenatal ultrasound diagnosis of cavitation of ganglionic eminence
  102. Higher rate of early-onset preeclampsia in pregnancies following oocyte donation according to increasing maternal age
  103. Intracervical lakes as a sonographic marker of placenta accreta spectrum (PAS) in patients with previa and low‐lying placenta
  104. Effects of Antenatal Betamethasone on Fetal Doppler Indices and Short Term Fetal Heart Rate Variation in Early Growth Restricted Fetuses
  105. Agreement between anatomical M‐mode and tissue Doppler imaging in the assessment of fetal atrioventricular annular plane displacement in uncomplicated pregnancies: A prospective longitudinal study
  106. Ultrasound evaluation of left ventricular and aortic fibrosis after HELLP syndrome
  107. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA
  108. Prenatal findings in oral‐facial‐digital syndrome type VI: Report of three cases and literature review
  109. Fetal anemia: Diagnosis and management
  110. Interobserver variability in MRI assessment of the severity of placenta accreta spectrum disorders
  111. Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert
  112. The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis
  113. Early Intraperitoneal Transfusion for Fetal Hydrops Caused by Parvovirus B19 Infection
  114. Evaluation of the quality and reliability of middle cerebral artery and umbilical artery Doppler images within an international randomized controlled trial
  115. Maternal blood flow to the placenta
  116. Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery
  117. Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts
  118. Comparative analysis of the 2‐year outcomes in the GRIT and TRUFFLE trials
  119. Birthweight discordance and neonatal morbidity in twin pregnancies: A systematic review and meta‐analysis
  120. Comparison of two “a priori” risk assessment algorithms for preeclampsia in Italy: a prospective multicenter study
  121. Elastic properties of ascending aorta and ventricular–arterial coupling in women with previous pregnancy complicated by HELLP syndrome
  122. The use of ultrasound-indicated cerclage or cervical pessary in asymptomatic twin pregnancies with a short cervix at midgestation
  123. TRAP Sequence in Monochorionic/Monoamniotic (MC/MA) Discordant Twins: Two Cases Treated with Fetoscopic Laser Surgery
  124. Ultrasonography Diagnosis
  125. Inappropriate left ventricular mass after preeclampsia: another piece of the puzzle Inappropriate LVM and PE
  126. Maternal functional hemodynamics in uncomplicated twin pregnancies: a longitudinal study using impedance cardiography
  127. Ultrasound evaluation of left ventricular and aortic fibrosis after pre-eclampsia
  128. Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study
  129. PMD38 - CELL-FREE FETAL DNA AS A CONTINGENT PRENATAL SCREENING OF TRISOMIES CONDITIONAL TO A RISK ≥ 1:1,000 FOR ITALIAN PREGNANT WOMEN: AN ECONOMIC EVALUATION
  130. Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome
  131. Pre-eclampsia and heart failure: a close relationship
  132. Perinatal mortality, timing of delivery and prenatal management of monoamniotic twin pregnancies: systematic review and meta-analysis al
  133. The Effect of Chorionicity on Maternal Cardiac Adaptation to Uncomplicated Twin Pregnancy: A Prospective Longitudinal Study
  134. Prophylaxis for Fetal Growth Restriction: Aspirin and Low-Molecular-Weight Heparins
  135. Planned Home Versus Planned Hospital Births in Women at Low-Risk Pregnancy: A Systematic Review With Meta-analysis
  136. Prenatal management and timing of delivery of uncomplicated monochorionic monoamniotic twin pregnancy: the MONOMONO study
  137. Twin-to-twin-transfusion syndrome: from amniodrainage to laser
  138. Etiology and Prognosis of Severe Ventriculomegaly Diagnosed at Late Gestation
  139. Weight discordance and perinatal mortality in twin pregnancy: systematic review and meta-analysis
  140. Longitudinal reference ranges for serial measurements of myocardial performance index (MPI) by conventional and pulsed-wave tissue Doppler in monochorionic diamniotic twins at 17 to 26 weeks of gestation
  141. Randomised Italian Sonography for Occiput POSition Trial Ante Vacuum (R.I.S.POS.T.A.)
  142. Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise
  143. Perinatal Outcome of Fetal Umbilical Vein Varix
  144. Brain-injured Survivors of Monochorionic Twin Pregnancies Complicated by Single Intrauterine Death: MR Findings in a Multicenter Study
  145. Cervical-length measurement in mid-gestation to predict spontaneous preterm birth in asymptomatic triplet pregnancy
  146. Management of monochorionic twin pregnancy discordant for body-stalk anomaly
  147. Planned home versus planned hospital births in women at low-risk pregnancy: A systematic review with meta-analysis
  148. Endometriosis, endometrioma, and ART results: Current understanding and recommended practices
  149. Changes in ductus venosus velocity ratios after fetoscopic laser surgery for twin-twin transfusion syndrome
  150. Acetylsalicylic acid in pregnant women with chronic hypertension
  151. 122: Timing of delivery of uncomplicated monochorionic monoamniotic twins
  152. Maternal endothelial function and vascular stiffness after HELLP syndrome: a case-control study
  153. First-trimester screening for pre-eclampsia: time for reflection
  154. Maternal cardiac function after HELLP syndrome: an echocardiography study
  155. Economic Analysis of The Use of Non-Invasive Prenatal Test (NIPT) For Prenatal Screening of Trisomy 21, 18, 13 In Pregnant Women
  156. Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study
  157. Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study
  158. A multi-centre, non-inferiority, randomised controlled trial to compare a cervical pessary with a cervical cerclage in the prevention of preterm delivery in women with short cervical length and a history of preterm birth – PC study
  159. Comparative X-ray morphometry of prenatal osteogenesis imperfecta type 2 and thanatophoric dysplasia: a contribution to prenatal differential diagnosis
  160. Longitudinal study of computerized cardiotocography in early fetal growth restriction
  161. How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post-hoc analysis of TRUFFLE study
  162. Early prediction of twin-to-twin transfusion syndrome: systematic review and meta-analysis
  163. Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction?
  164. Late appearance of umbilical artery end-diastolic flow in selective intrauterine growth restriction complicating monochorionic diamniotic twin pregnancy
  165. Chromosomal Microarray and Fetal Growth Restriction
  166. Correlation between fetal autopsy and prenatal diagnosis by ultrasound: A systematic review
  167. The search for the ideal microbiota in human reproduction
  168. Re: Validation of a first-trimester screening model for pre-eclampsia in an unselected population. E. Scazzocchio, F. Crovetto, S. Triunfo, E. Gratacós and F. Figueras.Ultrasound Obstet Gynecol2017; 49: 188-193.
  169. Early onset fetal growth restriction
  170. Development of Customized Fetal Growth Charts in Twins
  171. Validation of predictive models for pre-eclampsia
  172. Counselling about the Risk of Preterm Delivery: A Systematic Review
  173. Phase-rectified signal averaging method to predict perinatal outcome in infants with very preterm fetal growth restriction- a secondary analysis of TRUFFLE-trial
  174. Cervical Length at Mid-gestation in Screening for Preterm Birth in Twin Pregnancy
  175. Outcomes Associated With Isolated Agenesis of the Corpus Callosum: A Meta-analysis
  176. Cervical length at mid-gestation in screening for preterm birth in twin pregnancy
  177. Surgery for endometriosis and outcome of IVF-ET: systematic review and meta-analysis
  178. Intertwin discrepancy in middle cerebral artery peak systolic velocity and third-trimester fetal growth restriction in monochorionic-diamniotic twin pregnancy
  179. Fetal heart monitoring in labour: from pinard to artificial intelligence
  180. Reply
  181. Predicting outcome in 259 fetuses with agenesis of ductus venosus – a multicenter experience and systematic review of the literature
  182. The effect of fetal sex on customized fetal growth charts
  183. Circular RNA and pre-eclampsia: on the long road from the laboratory to the bedside
  184. Elastic properties of ascending aorta in women with previous pregnancy complicated by early- or late-onset pre-eclampsia
  185. 256: Prediction of outcome in 255 fetuses with absent ductus venosus - a multicenter experience and literature review
  186. Customized Fetal Growth Charts for Parents' Characteristics, Race, and Parity by Quantile Regression Analysis
  187. Amniocentesis for fetal karyotyping: the end of an era?
  188. Placental morphology in pregnancies associated with pregravid obesity
  189. 2 Year Neurodevelopmental and Intermediate Perinatal Outcomes in Infants With Very Preterm Fetal Growth Restriction (TRUFFLE)
  190. Outcome of monochorionic diamniotic twin pregnancies followed at a single center
  191. Microwave Ablation in Complicated Monochorionic Twin Pregnancies
  192. Neonatal morbidity after cesarean section before labor at 34+0to 38+6weeks: a cohort study
  193. Polyhydramnios in sac of parasitic twin: atypical manifestation of twin reversed arterial perfusion sequence
  194. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
  195. The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus
  196. Reply: fruit and fetal brain MRI - the cherry-picking approach to systematic reviews
  197. Quality of first trimester risk prediction models for pre-eclampsia: a systematic review
  198. Re: Transverse vaginal septae: management and long-term outcomes
  199. Reply: Apples, oranges and fetal brain MRI
  200. The natural history of monoamniotic twin pregnancies: a case series and systematic review of the literature
  201. Re: Iatrogenic perforation of intertwin membrane after laser surgery for twin‐to‐twin transfusion syndrome. S. H. P. Peeters, T. T. Stolk, F. Slaghekke, J. M. Middeldorp, F. J. Klumper, E. Lopriore and D. Oepkes. Ultrasound Obstet Gynecol 2014; 44: 550...
  202. Fetal cardiac parameters for prediction of twin‐to‐twin transfusion syndrome
  203. Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis
  204. OC23.05: Inter-twin discordance in mean cerebral artery peak systolic velocity and pregnancy outcome in monochorionic diamniotic twin pregnancies
  205. OP11.04: Fetal cardiac parameters for the prediction of twin-twin transfusion syndrome
  206. OP11.10: Spontaneous preterm birth in triplet pregnancies is independent from cervical length measurement at mid-gestation
  207. OP30.04: Cervical length measurement in twin pregnancies at 18-22 weeks: not the best test for all preterm births
  208. P02.15: Body stalk anomaly in monoamniotic twins at 9 weeks
  209. P14.31: First trimester risk prediction models for pre-eclampsia based on uterine artery Doppler: a systematic review of methodology
  210. P19.12: The natural history of monoamniotic twin pregnancies
  211. P19.18: Polyhydramnios in the sac of the parasitic twin: atypical manifestation of twin-reversed arterial perfusion sequence
  212. Additional value of fetal magnetic resonance imaging in the prenatal diagnosis of central nervous system anomalies: a systematic review of the literature
  213. Perinatal Outcomes of Twin Anemia–Polycythemia Sequence: A Systematic Review
  214. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis
  215. Concordant body stalk anomaly in a monoamniotic twin pregnancy at 9 weeks
  216. Re: Uterine artery Doppler and sFlt‐1/PlGF ratio: prognostic value in early‐onset pre‐eclampsia. P. I. Gómez‐Arriaga, I. Herraiz, E. A. López‐Jiménez, D. Escribano, B. Denk and A. Galindo. Ultrasound Obstet Gynecol 2014; 43: 525–532
  217. The prognostic role of various indices and ratios of Doppler velocimetry in patients with pre-eclampsia
  218. Fetal abdominal wall defects
  219. Fetal Surgery
  220. Rapid cervical phIGFBP-1 test in asymptomatic twin pregnancies: role in mid-pregnancy prediction of spontaneous preterm delivery
  221. Fetoscopic cord transection for treatment of monoamniotic twin reversed arterial perfusion sequence
  222. 203: The effects of vanishing twin on perinatal outcomes of the co-twin: a systematic review with meta-analysis
  223. Fetal weight estimation in gestational diabetic pregnancies: comparison between conventional and three-dimensional fractional thigh volume methods using gestation-adjusted projection
  224. Accuracy of Ultrasonography at 11–14 Weeks of Gestation for Detection of Fetal Structural Anomalies
  225. Comment on “Long‐term outcomes of children with umbilical vein varix diagnosed prenatally”
  226. Prevention, Management, and Outcomes of Macrosomia
  227. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
  228. Pregnancy week at delivery and the risk of shoulder dystocia: a population study of 2 014 956 deliveries
  229. Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R
  230. Perinatal outcomes of isolated oligohydramnios at term and post-term pregnancy: a systematic review of literature with meta-analysis
  231. Preliminary experience with microwave ablation for selective feticide in monochorionic twin pregnancies
  232. Cervical cerclage in twin pregnancies
  233. The use of radiofrequency in the treatment of twin reversed arterial perfusion sequence: a case series and review of the literature
  234. Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature
  235. Re: Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature. A. C. Rossi and F. Prefumo. Ultrasound Obstet Gynecol 2013; 41: 131–135
  236. ISUOG Practice Guidelines: use of Doppler ultrasonography in obstetrics
  237. Effects of antenatal recognition and follow‐up on perinatal outcomes in small‐for‐gestational age infants delivered after 36 weeks
  238. I299 EVIDENCE‐BASED APPLICATION OF 3D/4D ULTRASOUND IN FETAL MEDICINE: OVERVIEW
  239. Re: Effect of letrozole on uterine artery Doppler flow indices prior to first-trimester termination of pregnancy: a randomized controlled trial. V. C. Y. Lee, T. W. Y. Yeung, O. S. Tang, E. H. Y. Ng, W. S. B. Yeung and P. C. Ho. Ultrasound Obstet Gynecol
  240. OP06.07: Preliminary experience with microwave ablation for selective feticide in monochorionic twin pregnancies
  241. P08.15: The role of uterine artery pulsatility index for prediction of outcome in pregnancies complicated by pre-eclampsia
  242. PP110. The role of doppler to predict adverse pregnancy outcome in patients with pre-eclampsia
  243. Conservative management in a case of iatrogenic twin anemia–polycythemia sequence
  244. Effects of Epidural Analgesia on Uterine Artery Doppler in Labor
  245. OC09.02: Complications and outcome of invasive prenatal diagnosis in twin pregnancies
  246. The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women
  247. Successful management of a triplet heterotopic caesarean scar pregnancy after in vitro fertilization-embryo transfer
  248. Nuchal translucency thickness and crown rump length discordance for the prediction of outcome in monochorionic diamniotic pregnancies
  249. Practice guidelines for performance of the routine mid‐trimester fetal ultrasound scan
  250. Effects of epidural analgesia on uterine artery Doppler in labour
  251. P19.05: Obstetric and perinatal outcomes in triplet pregnancies in relation to chorionicity
  252. OC03.05: Effects of antenatal identification on perinatal outcomes in small for gestational age infants delivered after 34 weeks' gestation
  253. P06.09: Fetoscopic laser treatment for twin–twin transfusion syndrome: preliminary results from a new Italian center
  254. OP06.01: A systematic review of first trimester nuchal translucency for the prediction of twin‐to‐twin transfusion syndrome
  255. A randomized controlled trial of 24‐hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score ≤ 4
  256. Single umbilical artery and congenital heart disease in selected and unselected populations
  257. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin‐to‐twin transfusion syndrome
  258. Stepwise sequential screening for trisomy 21 in assisted reproduction pregnancies
  259. OP11.11: Effects of epidural analgesia on uterine artery Doppler in labour
  260. P06.08: Successful management of a heterotopic twin pregnancy on Cesarean scar combined with a viable intrauterine pregnancy
  261. P26.06: Increased concentrations of antiangiogenic factors in mirror syndrome complicating TTTS
  262. P05.16: Interobserver repeatability of transabdominal 3D ultrasound of the fetal brain
  263. OC26.02: Fetal weight estimation in pregnancy complicated by obesity: comparison between conventional and a new 3D ultrasound method
  264. OP14.03: Longitudinal study of maternal insulin-like growth factor-I and uterine artery Doppler
  265. OC20.01: Cardiovascular function in women with a previous pregnancy complicated by early onset pre-eclampsia
  266. OP18.03: Nuchal translucency thickness discordance for prediction of severe twin-twin transfusion syndrome
  267. OP34.05: Outcome of monochorionic diamniotic pregnancies followed at a single Twin Clinic
  268. Interobserver Reproducibility of Transabdominal 3-Dimensional Sonography of the Fetal Brain
  269. First‐trimester uterine artery Doppler indices in the prediction of small‐for‐gestational age pregnancy and intrauterine growth restriction
  270. Association of Uterine Artery Doppler Resistance Index and Birth Weight: Effect of Customized Birth Weight Standards
  271. Adnexal torsion in late pregnancy
  272. Stepwise sequential screening for trisomy 21 in assisted reproduction pregnancies
  273. Pulse wave analysis: a preliminary study of a novel technique for the prediction of pre-eclampsia
  274. First trimester uterine artery Doppler in women with previous pre‐eclampsia
  275. Prenatal imaging of ductus venosus agenesis using 4D ultrasound with a matrix array transducer
  276. First‐trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine
  277. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin
  278. Acute Premature Constriction of the Ductus Arteriosus after Maternal Self-Medication with Nimesulide
  279. Association between birth weight and first-trimester free β–human chorionic gonadotropin and pregnancy-associated plasma protein A
  280. Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction
  281. Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein
  282. Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker
  283. P41.03: Uterine artery Doppler at 10–14 weeks and maternal serum concentrations of asymmetric dimethylarginine
  284. OP01.10: Third trimester uterine artery Doppler and adverse obstetric outcome
  285. OP13.08: Corpus callosum abnormalities: 2D, 3D ultrasound and MRI
  286. P27.14: Fetal cystic hygroma and mid‐trimester maternal serum screening
  287. OP14.01: Uterine artery Doppler at 10–14 weeks and the interaction between decidual NK cells and extravillous trophoblast: an immunohistochemical study
  288. OP01.03: Maternal cardiovascular function and ambulatory blood pressure monitoring in pregnancies complicated by fetal growth restriction
  289. OC138: The combination of short cervical length and phIGFBP‐1 in the prediction of preterm delivery
  290. P32.17: Real‐time 3D ultrasound using a matrix array transducer: a case of agenesis of the ductus venosus
  291. OP19.05: A comparison of cervical length measurement and phIGFBP‐1 in the prediction of preterm delivery
  292. Cystic hygroma and mid-trimester maternal serum screening
  293. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
  294. Matrix Array Transducers in Fetal Heart Imaging
  295. Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
  296. Apparently isolated borderline ventriculomegaly and lissencephaly
  297. Outcome of prenatally diagnosed agenesis of the corpus callosum
  298. First‐trimester uterine artery Doppler and spontaneous preterm delivery
  299. Analysis of Natural Killer Cells Isolated from Human Decidua: Evidence that 2B4 (CD244) Functions as an Inhibitory Receptor and Blocks NK Cell Function
  300. Maternal and neonatal outcome after failed ventouse delivery: Comparison of forceps versus cesarean section
  301. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function
  302. Maternal cardiac function in early pregnancies with high uterine artery resistance
  303. Uterine artery Doppler velocimetry at 11–14 weeks in singleton pregnancies conceived by assisted reproductive technology
  304. Correlation between first-trimester uterine artery Doppler indices and maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A
  305. Correlation between first trimester fetal bone length and maternal serum pregnancy-associated plasma protein-A (PAPP-A)
  306. P04.18: Acute premature constriction of the ductus arteriosus after maternal self‐medication with nimesulide
  307. P07.01: First‐trimester uterine artery Doppler in women with previous pre‐eclampsia
  308. OP07.01: First‐trimester uterine artery Doppler and spontaneous preterm delivery
  309. OP07.03: First‐trimester uterine artery Doppler and small‐for‐gestational‐age infants
  310. OP18.02: Contrast‐enhanced ultrasound (CEU) before and after uterine artery embolisation (UAE) for fibroid treatment
  311. P14.06: Difficult differential diagnosis of an occipital mass
  312. P07.02: First‐trimester uterine artery Doppler and pre‐eclampsia
  313. OC117: Transvaginal ultrasound (TVUS) and sonohysterography (SHG) in the preoperative staging of submucous fibroids
  314. OP13.03: Assessment of palpable nodules of the abdominal wall with postpartum onset
  315. P14.03: Prenatal diagnosis of septal agenesis with normal pituitary function
  316. P02.72: Prenatal diagnosis of Meckel–Gruber syndrome in a pregnancy deriving from ICSI
  317. OC75: Differential diagnosis of uterine myomas and adenomyosis by color Doppler (CD) and contrast‐enhanced ultrasound (CEU)
  318. Assessment of the intraobserver variability in the measurement of fetal cardiothoracic ratio using ellipse and diameter methods
  319. Prenatal Diagnosis of Meckel–Gruber Syndrome in a Pregnancy Obtained With ICSI
  320. Influence of parity on first trimester endovascular trophoblast invasion
  321. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  322. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations
  323. Clinical implications of an anatomical variant of the ductus venosus
  324. Effect of inter-twin delivery interval on neonatal haemoglobin concentration
  325. Prenatal diagnosis of septal agenesis with normal pituitary function
  326. Prenatal diagnosis of a nasal glioma in the mid trimester
  327. Association of first trimester uterine artery Doppler, maternal diastolic cardiac function and ischaemia modified albumin
  328. Trisomy18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result
  329. The association between p53 expression, stage and histological features in endometrial cancer
  330. P15.12: Association of first trimester uterine artery Doppler indices with maternal diastolic cardiac function
  331. OC32.02: First‐trimester uterine artery Doppler and ischaemia modified albumin in women who subsequently develop severe pre‐eclampsia
  332. A newly described thoracic vascular malformation in fetuses with Down syndrome
  333. Acute Presentation of Fetal Hypertrophic Cardiomyopathy in a Type 1 Diabetic Pregnancy
  334. First-Trimester Ductus Venosus, Nasal Bones, and Down Syndrome in a High-Risk Population
  335. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy
  336. First-trimester fetal nuchal translucency and inherited metabolic disorders
  337. Prenatal sonographic findings in a case of Varadi–Papp syndrome
  338. Second‐trimester uterine artery Doppler and spontaneous preterm delivery
  339. P10.08: First trimester nasal bones and trisomy 21 in a low‐risk population
  340. P10.09: First trimester ductus venosus, nasal bones and trisomy 21 in a high‐risk population
  341. OC007: Long axis ventricular function in normal fetuses
  342. OC154: Pregnancy outcome of antenatally diagnosed agenesis of the corpus callosum
  343. OC027: Single umbilical artery and congenital heart disease in high‐ and low‐risk populations
  344. P14.42: Sonographic resolution of severe uretero‐pelvic junction obstruction in utero associated with complete absence of neonatal kidney function
  345. P11.12: Fetal Gollop‐Wolfgang complex associated with de novo chromosomal rearrangements typical of split‐hand/split‐foot anomaly
  346. OC046: The investigation of fetal arrhythmias by simultaneous pulsed wave Doppler recording of pulmonary artery and vein
  347. P08.01: Relationship of uterine artery Doppler and trophoblast invasion in the first trimester of pregnancy
  348. P01.03: Assessment of the intra‐observer variability in the measurement of fetal cardio‐thoracic ratio using ellipse and diameter methods
  349. OC065: Uterine artery resistance at 10–14 weeks of gestation is correlated with trophoblast apoptosis
  350. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae
  351. Ultrasound prenatal diagnosis of a lateral facial cleft (Tessier number 7)
  352. Vasa Previa: The Impact of Prenatal Diagnosis on Outcomes
  353. The Longitudinal Variation in Uterine Artery Blood Flow Pattern in Relation to Birth Weight
  354. Primary and secondary malignancies of the penis: ultrasound features
  355. Maternal ethnic origin and fetal nasal bones at 11–14 weeks of gestation
  356. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae
  357. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices
  358. Decreased endovascular trophoblast invasion in first-trimester pregnancies with high-resistance uterine artery doppler indices
  359. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms
  360. Ultrasound-guided interstitial laser therapy for the treatment of placental chorioangioma
  361. Ultrasound-Guided Interstitial Laser Therapy for the Treatment of Placental Chorioangioma
  362. First‐trimester uterine artery blood flow and birth weight
  363. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia
  364. Cardiac surgery during pregnancy: pulsatile or nonpulsatile perfusion?
  365. Early resolution of increased nuchal translucency in a fetus with trisomy 18
  366. Effect of fetal gender on first‐trimester ductus venosus blood flow
  367. Association between increased nuchal translucency and second trimester cardiac echogenic foci*1
  368. Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity
  369. Association Between Increased Nuchal Translucency and Second Trimester Cardiac Echogenic Foci
  370. Early vaginal bleeding and first‐trimester markers for Down syndrome
  371. The role of oxytocin in parturition
  372. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests
  373. Nuchal Translucency and Early Diagnosis of Congenital Anomalies
  374. Analysis of p53 and c-erbB-2 Expression in Ovarian Endometrioid Carcinomas Arising in Endometriosis
  375. OC202: Longitudinal variation of uterine artery waveforms and birthweight
  376. P300: Natural and unnatural history of first trimester cardiac diverticula
  377. P172: Ultrasound prenatal diagnosis of a lateral facial cleft (Tessier n. 7)
  378. P022: The correlation between early pregnancy ultrasound measurements and fetal nuchal translucency
  379. P020: Second trimester uterine artery Dopplers and preterm delivery
  380. P018: Maternal haematological parameters and uterine artery bloodflow
  381. OC020: Is the discriminatory zone an outdated concept?
  382. The sonographic evaluation of tubal patency with stimulated acoustic emission imaging
  383. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  384. Reference values for ductus venosus Doppler flow measurements at 10–14 weeks of gestation
  385. Trisomy 18 in a fetus with normal NT and abnormal maternal serum biochemistry
  386. Reference values for fetal limb biometry at 10–14 weeks of gestation
  387. Epithelial Abnormalities in Cystic Ovarian Endometriosis
  388. Comparison of First Trimester, Second Trimester and Integrated Downs Syndrome Screening Results in Unaffected Pregnancies
  389. A defective expression of ICAM-1 (CD54) on secretory endometrial cells is associated with endometriosis
  390. Isolated echogenic foci in the fetal heart: do they increase the risk of trisomy 21 in a population previously screened by nuchal translucency?
  391. Reproducibility of ductus venosus Doppler flow measurements at 11–14 weeks of gestation
  392. Prenatal diagnosis of mosaic trisomy 8 in a fetus with normal nuchal translucency thickness and reversed end‐diastolic ductus venosus flow
  393. Antenatal diagnosis of fetal intra‐abdominal umbilical vein dilatation
  394. The prenatal diagnosis of Binder syndrome before 24 weeks of gestation: case report
  395. Extent of correlation between first and second trimester markers for Down's syndrome screening
  396. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation
  397. Reply